1 results match your criteria: "Vanderbilt University School of Medicine; Nashville[Affiliation]"
Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Am J Respir Crit Care Med
November 2009
Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Rationale: The receptor for advanced glycation end products (RAGE) is an important marker of lung epithelial injury and may be associated with impaired alveolar fluid clearance. We hypothesized that patients with primary graft dysfunction (PGD) after lung transplantation would have higher RAGE levels in plasma than patients without PGD.
Objectives: To test the association of soluble RAGE (sRAGE) levels with PGD in a prospective, multicenter cohort study.